BRAND_ANALYSIS#GLAXOSMITHKLINEHEALTH & PHARMA#3 OF 26 IN HEALTH & PHARMAHIGH TENSION
GlaxoSmithKline
· Public · Updated 09 Jul 2026 08:27 UTC
#33 of 1208 overall by tension · #3 of 26 in Health & Pharma
33High Tension
The Silent Giant
Analysis
GSK's C=40 is the second-lowest cultural score in the pharma bracket, and sentiment at 0.20 reflects a company that changed its name from GlaxoSmithKline to GSK and then back to GlaxoSmithKline in brand identity terms without resolving anything. The 1.94% gain and B=73 are below the batch average. T=33 is where brands idle when they've stopped telling a story.
IN THE NEWS (23 articles this week)
GSK PLC | British Pharmaceutical & Biotechnology Company - Encyclopedia Britannica
HSBC upgrades GlaxoSmithKline stock rating on pipeline investment By Investing.com - Investing.com
Enterprise value to EBITDA forward of GlaxoSmithKline S.A.E. – EGX:BIOC - TradingView